44 results
8-K
LYEL
Lyell Immunopharma, Inc.
20 Nov 23
Departure of Directors or Certain Officers
4:26pm
) a Change in Control, as defined in the Company’s Officer Severance Plan; and (iii) the optionholder’s death or Disability (as defined
8-K
EX-10.1
hbvvm
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
DEF 14A
bwmxapnti
28 Apr 22
Definitive proxy
4:11pm
10-K
EX-10.8
z5slbq4twc2z56p66h
29 Mar 22
Annual report
4:20pm
8-K
c3fo 8qfy3ho4
15 Feb 22
Departure of Directors or Certain Officers
4:47pm
S-8
EX-4.2
a8caj6826s6w
21 Jun 21
Registration of securities for employees
5:08pm
S-8
EX-99.3
qtnyc yslt9jxb6
21 Jun 21
Registration of securities for employees
5:08pm
424B4
26tpha54
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
qbe1g6ojl6wacmr2hgu
9 Jun 21
IPO registration (amended)
7:12am
S-1/A
EX-10.15
26jo8k
9 Jun 21
IPO registration (amended)
7:12am
S-1/A
EX-10.4
d1cpdg7hyt7r61 qujb
9 Jun 21
IPO registration (amended)
7:12am
S-1/A
EX-3.4
gb96a0c 5gra2h
9 Jun 21
IPO registration (amended)
7:12am
S-1/A
EX-10.3
f46hg3k43cpzav0yvtvv
9 Jun 21
IPO registration (amended)
7:12am
S-1
EX-10.22
h3z2sqjs
25 May 21
IPO registration
5:28pm
S-1
EX-10.8
wq7nhli4o7z9
25 May 21
IPO registration
5:28pm
S-1
EX-10.15
kubtnprj
25 May 21
IPO registration
5:28pm